| Dr Thomas Joseph Hornyak, MD, PHD | |
|
10 Center Dr, Building 10, Room 12n242, Msc1908, Bethesda, MD 20892-0001 | |
| (301) 451-1926 | |
| (301) 496-5370 |
| Full Name | Dr Thomas Joseph Hornyak |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 32 Years |
| Location | 10 Center Dr, Bethesda, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306980602 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 4301073444 (Michigan) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Maryland Dermatologists Pa | 7810888484 | 10 |
News Archive
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes coronavirus disease (COVID-19), is still actively spreading like wildfire, with nearly 300,000 new infections reported daily across the globe. Early on in the outbreak in China, scientists said that the virus could spread through respiratory droplets, when a person coughs, sneezes, or speaks.
A new study from the HSE University researchers Elena Gorbunova and Maria Falikman reveals that when reading off a screen, an individual tends to comprehend the words on the right side of the screen faster than those on the left. The processing speed of the information of the brain also depends on the amount of information presented on the screen explain the researchers. The study titled, "Visual Search for Letters in the Right Versus Left Visual Hemifields," was published in the journal, Advances in Cognitive Psychology.
Oxford BioMedica plc, the leading gene-based biopharmaceutical company, today announces that the US Food and Drug Administration has approved its Investigational New Drug application for the Phase I/IIa clinical development of UshStat, a novel gene-based treatment for Usher syndrome type 1B.
The authors recommend that low-cost, nonhospital-based preventive care be promoted to reduce patient deaths after hospital closures.
Merck, known as MSD outside of the United States and Canada, today announced new data from HIV/HCV co-infected patients in the ongoing C-WORTHY Study, a Phase 2 clinical trial evaluating the efficacy and safety of Merck's all-oral, once-daily regimen combining MK-5172, an investigational hepatitis C virus (HCV) NS3/4A protease inhibitor, and MK-8742, an investigational HCV NS5A replication complex inhibitor.
› Verified 3 days ago
| Entity Name | University Of Maryland Dermatologists Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659304152 PECOS PAC ID: 7810888484 Enrollment ID: O20040323000770 |
News Archive
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes coronavirus disease (COVID-19), is still actively spreading like wildfire, with nearly 300,000 new infections reported daily across the globe. Early on in the outbreak in China, scientists said that the virus could spread through respiratory droplets, when a person coughs, sneezes, or speaks.
A new study from the HSE University researchers Elena Gorbunova and Maria Falikman reveals that when reading off a screen, an individual tends to comprehend the words on the right side of the screen faster than those on the left. The processing speed of the information of the brain also depends on the amount of information presented on the screen explain the researchers. The study titled, "Visual Search for Letters in the Right Versus Left Visual Hemifields," was published in the journal, Advances in Cognitive Psychology.
Oxford BioMedica plc, the leading gene-based biopharmaceutical company, today announces that the US Food and Drug Administration has approved its Investigational New Drug application for the Phase I/IIa clinical development of UshStat, a novel gene-based treatment for Usher syndrome type 1B.
The authors recommend that low-cost, nonhospital-based preventive care be promoted to reduce patient deaths after hospital closures.
Merck, known as MSD outside of the United States and Canada, today announced new data from HIV/HCV co-infected patients in the ongoing C-WORTHY Study, a Phase 2 clinical trial evaluating the efficacy and safety of Merck's all-oral, once-daily regimen combining MK-5172, an investigational hepatitis C virus (HCV) NS3/4A protease inhibitor, and MK-8742, an investigational HCV NS5A replication complex inhibitor.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas Joseph Hornyak, MD, PHD 5909 Kingswood Rd, Bethesda, MD 20814-1821 Ph: (301) 897-2992 | Dr Thomas Joseph Hornyak, MD, PHD 10 Center Dr, Building 10, Room 12n242, Msc1908, Bethesda, MD 20892-0001 Ph: (301) 451-1926 |
News Archive
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes coronavirus disease (COVID-19), is still actively spreading like wildfire, with nearly 300,000 new infections reported daily across the globe. Early on in the outbreak in China, scientists said that the virus could spread through respiratory droplets, when a person coughs, sneezes, or speaks.
A new study from the HSE University researchers Elena Gorbunova and Maria Falikman reveals that when reading off a screen, an individual tends to comprehend the words on the right side of the screen faster than those on the left. The processing speed of the information of the brain also depends on the amount of information presented on the screen explain the researchers. The study titled, "Visual Search for Letters in the Right Versus Left Visual Hemifields," was published in the journal, Advances in Cognitive Psychology.
Oxford BioMedica plc, the leading gene-based biopharmaceutical company, today announces that the US Food and Drug Administration has approved its Investigational New Drug application for the Phase I/IIa clinical development of UshStat, a novel gene-based treatment for Usher syndrome type 1B.
The authors recommend that low-cost, nonhospital-based preventive care be promoted to reduce patient deaths after hospital closures.
Merck, known as MSD outside of the United States and Canada, today announced new data from HIV/HCV co-infected patients in the ongoing C-WORTHY Study, a Phase 2 clinical trial evaluating the efficacy and safety of Merck's all-oral, once-daily regimen combining MK-5172, an investigational hepatitis C virus (HCV) NS3/4A protease inhibitor, and MK-8742, an investigational HCV NS5A replication complex inhibitor.
› Verified 3 days ago
Dr. Liesl Shockley Grenier, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 8901 Rockville Pike, Bethesda, MD 20889 Phone: 301-295-4000 | |
Anita Iyer, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6500 Rock Spring Dr Ste 105, Bethesda, MD 20817 Phone: 301-530-8300 Fax: 301-530-4638 | |
Dr. Leonard Charles Sperling, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 8901 Rockville Pike, Bethesda, MD 20889 Phone: 301-943-9239 Fax: 301-295-3150 | |
Dr. Boris D Lushniak, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 8901 Wisconsin Ave, Nnmc Dept Of Professional Affairs, Bethesda, MD 20889 Phone: 301-295-6231 Fax: 301-295-5928 | |
Dr. Caitlin Fink, D.O. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 8901 Wisconsin Ave, Bethesda, MD 20889 Phone: 301-295-4551 | |
Dr. Mary Margaret Mancewicz, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5909 Kingswood Rd, Bethesda, MD 20814 Phone: 301-897-2992 | |
Dr. Iris Kedar Rubin, MD Dermatology Medicare: Medicare Enrolled Practice Location: 6410 Rockledge Dr, Suite 201, Bethesda, MD 20817 Phone: 301-530-8300 Fax: 301-530-8300 |